n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with caseins in 1 studies
| Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (caseins) | Trials (caseins) | Recent Studies (post-2010) (caseins) |
|---|---|---|---|---|---|
| 79 | 1 | 16 | 16,863 | 561 | 4,170 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazda, T; Ogasawara, K | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and caseins
| Article | Year |
|---|---|
Differences in substrate specificities for cysteine proteinases used in blood group serology, and the use of bromelain in a two-phase inhibitor technique.
Topics: Albumins; Blood Grouping and Crossmatching; Bromelains; Caseins; Cysteine Endopeptidases; Evaluation Studies as Topic; Ficain; Immunoenzyme Techniques; Leucine; Papain; Substrate Specificity | 1989 |